Ignite Creation Date:
2024-05-06 @ 5:47 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05437679
Status:
TERMINATED
Last Update Posted:
2023-09-05
First Post:
2022-06-27
Brief Title:
Characterization of Circulating Tumor Cells CTCs in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix System
Sponsor:
Organization:
Angle plc
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Whole blood samples will be collected and the following will be isolated from the whole blood samples serum plasma cells eg CTCs white blood cells etc circulating cell free DNA DNA and RNA from isolated cells etc
Enrollment Count:
9
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 86683 |
Who Masked List: